Target intelligence / Profile preview

CDC42 pseudogene 1 (CDC42P1)

Target
CDC42P1
Molecular classification
Other
01

Overview

CDC42 pseudogene 1 (CDC42P1) is a pseudogene in humans and does not encode a functional protein product. As a pseudogene, it shares sequence similarity with the active *CDC42* gene but lacks the capability to produce an active enzyme or receptor. Pseudogenes like CDC42P1 are generally considered genetically inactive, and there is no experimental evidence linking CDC42P1 to any biological function, disease role, or drug interactions[5]. *CDC42P1* is distinct from the functional *CDC42* gene, which encodes a small GTPase involved in key cellular processes, signaling, and cancer[1][3][4]. However, *CDC42P1* itself does not possess these functional properties and is not a therapeutic or druggable target[5]. No disease associations, biomarkers, or pharmacological interactions have been reported for CDC42P1[5]. This is consistent with standard conventions for molecular target annotation, where pseudogenes are classified as "Other" and not generally considered druggable or functionally relevant in the context of target-based drug discovery or therapeutics.

Other names
bK3216D2.3cell division cycle 42 (GTP binding protein, 25kDa) pseudogenecell division cycle 42 pseudogene 1

Beyond the preview

Go deeper on CDC42 pseudogene 1 (CDC42P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDC42 pseudogene 1 (CDC42P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call